Literature DB >> 29723035

Targeting IL-8 in Cystic Fibrosis: Enough but Not Too Much.

Oliver J McElvaney1, Noel G McElvaney1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29723035     DOI： 10.1165/rcmb.2018-0145ED

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  4 in total

Review 1.  Update in Cystic Fibrosis 2018.

Authors:  Bonnie W Ramsey; Gregory P Downey; Christopher H Goss
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

Review 2.  Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology.

Authors:  Javier Checa; Josep M Aran
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

3.  Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations.

Authors:  Clémence Martin; Théo Dhôte; Maha Zohra Ladjemi; Muriel Andrieu; Souganya Many; Vaarany Karunanithy; Frédéric Pène; Jennifer Da Silva; Pierre-Régis Burgel; Véronique Witko-Sarsat
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

4.  Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic.

Authors:  Giulia Baresi; Mauro Giacomelli; Daniele Moratto; Marco Chiarini; Immacolata Claudia Conforti; Rita Padoan; Piercarlo Poli; Silviana Timpano; Francesca Caldarale; Raffaele Badolato
Journal:  Front Pediatr       Date:  2021-07-06       Impact factor: 3.418
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.